Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

887 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase 1b open-label study of sodium selenate as a disease-modifying treatment for possible behavioral variant frontotemporal dementia.
Vivash L, Malpas CB, Meletis C, Gollant M, Eratne D, Li QX, McDonald S, O'Brien WT, Brodtmann A, Darby D, Kyndt C, Walterfang M, Hovens CM, Velakoulis D, O'Brien TJ. Vivash L, et al. Among authors: li qx. Alzheimers Dement (N Y). 2022 May 5;8(1):e12299. doi: 10.1002/trc2.12299. eCollection 2022. Alzheimers Dement (N Y). 2022. PMID: 35574563 Free PMC article.
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
Li QX, Villemagne VL, Doecke JD, Rembach A, Sarros S, Varghese S, McGlade A, Laughton KM, Pertile KK, Fowler CJ, Rumble RL, Trounson BO, Taddei K, Rainey-Smith SR, Laws SM, Robertson JS, Evered LA, Silbert B, Ellis KA, Rowe CC, Macaulay SL, Darby D, Martins RN, Ames D, Masters CL, Collins S; AIBL Research Group. Li QX, et al. J Alzheimers Dis. 2015;48(1):175-87. doi: 10.3233/JAD-150247. J Alzheimers Dis. 2015. PMID: 26401938
Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology.
Rembach A, Evered LA, Li QX, Nash T, Vidaurre L, Fowler CJ, Pertile KK, Rumble RL, Trounson BO, Maher S, Mooney F, Farrow M, Taddei K, Rainey-Smith S, Laws SM, Macaulay SL, Wilson W, Darby DG, Martins RN, Ames D, Collins S, Silbert B, Masters CL, Doecke JD; AIBL Research Group. Rembach A, et al. Among authors: li qx. Alzheimers Res Ther. 2015 Nov 19;7(1):71. doi: 10.1186/s13195-015-0157-7. Alzheimers Res Ther. 2015. PMID: 26581886 Free PMC article.
Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.
Doecke JD, Rembach A, Villemagne VL, Varghese S, Rainey-Smith S, Sarros S, Evered LA, Fowler CJ, Pertile KK, Rumble RL, Trounson B, Taddei K, Laws SM, Macaulay SL, Bush AI, Ellis KA, Martins R, Ames D, Silbert B, Vanderstichele H, Masters CL, Darby DG, Li QX, Collins S; AIBL Research Group. Doecke JD, et al. Among authors: li qx. J Alzheimers Dis. 2018;61(1):169-183. doi: 10.3233/JAD-170128. J Alzheimers Dis. 2018. PMID: 29171991
A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?
Eratne D, Loi SM, Walia N, Farrand S, Li QX, Varghese S, Walterfang M, Evans A, Mocellin R, Dhiman K, Gupta V, Malpas CB, Collins S, Masters CL, Velakoulis D. Eratne D, et al. Among authors: li qx. Aust N Z J Psychiatry. 2020 Jan;54(1):57-67. doi: 10.1177/0004867419857811. Epub 2019 Jun 21. Aust N Z J Psychiatry. 2020. PMID: 31220922
Cerebrospinal fluid neurofilament light chain is elevated in Niemann-Pick type C compared to psychiatric disorders and healthy controls and may be a marker of treatment response.
Eratne D, Loi SM, Li QX, Varghese S, McGlade A, Collins S, Masters CL, Velakoulis D, Walterfang M. Eratne D, et al. Among authors: li qx. Aust N Z J Psychiatry. 2020 Jun;54(6):648-649. doi: 10.1177/0004867419893431. Epub 2019 Dec 11. Aust N Z J Psychiatry. 2020. PMID: 31823653 No abstract available.
Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease.
Dhiman K, Gupta VB, Villemagne VL, Eratne D, Graham PL, Fowler C, Bourgeat P, Li QX, Collins S, Bush AI, Rowe CC, Masters CL, Ames D, Hone E, Blennow K, Zetterberg H, Martins RN. Dhiman K, et al. Among authors: li qx. Alzheimers Dement (Amst). 2020 Feb 27;12(1):e12005. doi: 10.1002/dad2.12005. eCollection 2020. Alzheimers Dement (Amst). 2020. PMID: 32211500 Free PMC article.
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings.
Eratne D, Loi SM, Li QX, Stehmann C, Malpas CB, Santillo A, Janelidze S, Cadwallader C, Walia N, Ney B, Lewis V, Senesi M, Fowler C, McGlade A, Varghese S, Ravanfar P, Kelso W, Farrand S, Keem M, Kang M, Goh AMY, Dhiman K, Gupta V, Watson R, Yassi N, Kaylor-Hughes C, Kanaan R, Perucca P, Dobson H, Vivash L, Ali R, O'Brien TJ, Hansson O, Zetterberg H, Blennow K, Walterfang M, Masters CL, Berkovic SF, Collins S, Velakoulis D; MiND Study Group. Eratne D, et al. Among authors: li qx. Alzheimers Dement. 2022 Nov;18(11):2218-2233. doi: 10.1002/alz.12549. Epub 2022 Feb 1. Alzheimers Dement. 2022. PMID: 35102694
Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives.
Eratne D, Janelidze S, Malpas CB, Loi S, Walterfang M, Merritt A, Diouf I, Blennow K, Zetterberg H, Cilia B, Wannan C, Bousman C, Everall I, Zalesky A, Jayaram M, Thomas N, Berkovic SF, Hansson O, Velakoulis D, Pantelis C, Santillo A; MiND Study Group. Eratne D, et al. Aust N Z J Psychiatry. 2022 Oct;56(10):1295-1305. doi: 10.1177/00048674211058684. Epub 2021 Nov 17. Aust N Z J Psychiatry. 2022. PMID: 35179048
887 results